On the impact of cannabis consumption on traffic safety: a driving simulator study with habitual cannabis consumers

Anne Tank  ¹ , Tobias Tietz  ² , Thomas Daldrup  ¹ , Holger Schwender  ² , Florence Hellen  ³ , Stefanie Ritz-Timme  ¹ , Benno Hartung  ⁴

PMID: 30701315 DOI: 10.1007/s00414-019-02006-3

This originally appeared at https://pubmed.ncbi.nlm.nih.gov/30701315/

Abstract

To contribute to the ongoing discussion about threshold limits of Δ9-tetrahydrocannabinol (THC) in road traffic, a driving simulator study with 15 habitually cannabis consuming test persons was conducted. Probands were tested on different routes after consumption of a maximum of three cannabis joints, each containing 300 μg THC/kg body weight (sober testing as well as testing directly, 3 and 6 h after cannabis consumption). Accompanying the drives, medical examinations including a blood sampling were performed. Driving faults and distinctive features in the medical examinations were allocated certain penalty points, which were then summed up and evaluated using the ANOVA model. The results showed that very high CIF values > 30 as well as serum THC concentrations > 15 ng/ml significantly increased the number of penalty points, but no direct correlation to the THC concentrations in serum and/or CIF values was detected. Instead, the point in time after cannabis consumption seems to play an important role concerning driving safety: significantly more driving faults were committed directly after consumption. Three hours after consumption, no significant increase of driving faults was seen. Six hours after consumption (during the so-called subacute phase), an increase of driving faults could be noted although not significant. Considering the limitation of our study (e.g. small test group, no placebo test persons, long lasting test situation with possible tiredness), further studies focusing on the time dependant impact of cannabis consumption on road traffic are required.

Cited by

• Interpol review of toxicology 2019-2022. Cheng JY, Hui JW, Chan WS, So MH, Hong YH, Leung WT, Ku KW, Yeung HS, Lo KM, Fung KM, Ip CY, Dao KL, Cheung BK.Forensic Sci Int Synerg. 2023;6:100303. doi: 10.1016/j.fsisyn.2022.100303. Epub 2022 Dec 29.PMID: 36597440Free PMC article.Review.No abstract available.
• Cannabis, Impaired Driving, and Road Safety: An Overview of Key Questions and Issues. Brands B, Di Ciano P, Mann RE.Front Psychiatry. 2021 Aug 19;12:641549. doi: 10.3389/fpsyt.2021.641549. eCollection 2021.PMID: 34489746Free PMC article.Review.
• Cannabis and driving ability. Sevigny EL.Curr Opin Psychol. 2021 Apr;38:75-79. doi: 10.1016/j.copsyc.2021.03.003. Epub 2021 Mar 17.PMID: 33839427Free PMC article.Review.
• Use and Reported Helpfulness of Cannabinoids Among Primary Care Patients in Vermont. Wershoven N, Kennedy AG, MacLean CD.J Prim Care Community Health. 2020 Jan-Dec;11:2150132720946954. doi: 10.1177/2150132720946954.PMID: 32757826Free PMC article.

References

1. Clin Chem. 2013 Mar;59(3):478-92 – PubMed